A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Anna Radomińska‐Pandya is a researcher at the University of Arkansas for Medical Sciences. Her work has focused on characterizing cannabinoid receptors in Ewing sarcoma cells as potential targets for anti-cancer drug development. Recent publications investigate the effects of natural and synthetic cannabinoids on Ewing sarcoma cell viability, exploring potential mechanisms via non-canonical CB receptors.
Radomińska‐Pandya's scholarship metrics include an h-index of 40, with over 5,994 total citations across 116 publications. She is recognized as a highly cited researcher. Her collaborations include work with Alicja Urbaniak, Amal Shoeib, Azure L. Yarbrough, and Lirit N. Franks, all at the University of Arkansas for Medical Sciences, with whom she shares multiple publications.
Metrics
- h-index: 40
- Publications: 116
- Citations: 6,008
Selected Publications
-
Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development (2021)
-
Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors (2021)
Collaboration Network
Top Collaborators
Amal Shoeib
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lori L. Hensley
Jacksonville State University (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Benjamin M. Ford
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lirit N. Franks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Alicja Urbaniak
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Azure L. Yarbrough
University of Arkansas for Medical Sciences
2 shared publications
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Paul L. Prather
University of Arkansas for Medical Sciences (US)
2 shared publications
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Karol Kacprzak
Adam Mickiewicz University in Poznań (PL)
1 shared publication
- Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
Lance Benson
University of Arkansas for Medical Sciences (US)
1 shared publication
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Shengyu Mu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Similar Researchers
Based on overlapping research topics
Azure L. Yarbrough
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Lirit N. Franks
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Amal Shoeib
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Kayla Hefner
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Pharmacological Effects and Toxicity Studies
Katie R. Ryan
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Cancer Cells and Metastasis
Taher M Yusufali
University of Arkansas for Medical Sciences
Cannabis and Cannabinoid Research
Receptor Mechanisms and Signaling
Pharmacological Effects and Toxicity Studies